Superiority of prophylaxis versus on-demand therapy with plasma protein-free recombinant FVIII formulated with sucrose (BAY 81-8973): LEOPOLD II study results

Kavakli, KaanYang, RenchiRusen, LuminitaBeckmann, HorstTseneklidou-Stoeter, DespinaEnriquez, Monika Maas2019-10-272019-10-2720141351-82161365-2516https://hdl.handle.net/11454/50148eninfo:eu-repo/semantics/closedAccessSuperiority of prophylaxis versus on-demand therapy with plasma protein-free recombinant FVIII formulated with sucrose (BAY 81-8973): LEOPOLD II study resultsConference Object209495WOS:000335009500377Q2